Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
J Biol Chem ; 289(32): 21937-49, 2014 Aug 08.
Artículo en Inglés | MEDLINE | ID: mdl-24928513

RESUMEN

The physiological function of urate is poorly understood. It may act as a danger signal, an antioxidant, or a substrate for heme peroxidases. Whether it reacts sufficiently rapidly with lactoperoxidase (LPO) to act as a physiological substrate remains unknown. LPO is a mammalian peroxidase that plays a key role in the innate immune defense by oxidizing thiocyanate to the bactericidal and fungicidal agent hypothiocyanite. We now demonstrate that urate is a good substrate for bovine LPO. Urate was oxidized by LPO to produce the electrophilic intermediates dehydrourate and 5-hydroxyisourate, which decayed to allantoin. In the presence of superoxide, high yields of hydroperoxides were formed by LPO and urate. Using stopped-flow spectroscopy, we determined rate constants for the reaction of urate with compound I (k1 = 1.1 × 10(7) M(-1) s(-1)) and compound II (k2 = 8.5 × 10(3) M(-1) s(-1)). During urate oxidation, LPO was diverted from its peroxidase cycle because hydrogen peroxide reacted with compound II to give compound III. At physiologically relevant concentrations, urate competed effectively with thiocyanate, the main substrate of LPO for oxidation, and inhibited production of hypothiocyanite. Similarly, hypothiocyanite-dependent killing of Pseudomonas aeruginosa was inhibited by urate. Allantoin was present in human saliva and associated with the concentration of LPO. When hydrogen peroxide was added to saliva, oxidation of urate was dependent on its concentration and peroxidase activity. Our findings establish urate as a likely physiological substrate for LPO that will influence host defense and give rise to reactive electrophilic metabolites.


Asunto(s)
Lactoperoxidasa/metabolismo , Tiocianatos/metabolismo , Ácido Úrico/metabolismo , Animales , Antibacterianos/metabolismo , Unión Competitiva , Bovinos , Humanos , Inmunidad Innata , Cinética , Lactoperoxidasa/inmunología , Modelos Biológicos , Oxidación-Reducción , Pseudomonas aeruginosa/inmunología , Saliva/inmunología , Saliva/metabolismo , Especificidad por Sustrato
2.
Eur Respir J ; 44(1): 122-9, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24659542

RESUMEN

Glutathione is an important antioxidant in the lungs but its concentration is low in the airways of patients with cystic fibrosis. Whether this deficit occurs from an early age or how oxidative stress contributes to lowering glutathione is unknown. We measured glutathione, its oxidation products, myeloperoxidase, and biomarkers of hypochlorous acid in bronchoalveolar lavage from children with cystic fibrosis and disease controls using mass spectrometry and immunological techniques. The concentration of glutathione was lower in bronchoalveolar lavage from children with cystic fibrosis, whereas glutathione sulfonamide, a specific oxidation product of hypochlorous acid, was higher. Oxidised glutathione and glutathione sulfonamide correlated with myeloperoxidase and a biomarker of hypochlorous acid. The percentage of glutathione attached to proteins was higher in children with cystic fibrosis than controls. Pulmonary infections in cystic fibrosis resulted in lower levels of glutathione but higher levels of oxidised glutathione and glutathione sulfonamide in bronchoalveolar lavage. The concentration of glutathione is low in the airways of patients with cystic fibrosis from an early age. Increased oxidation of glutathione by hypochlorous acid and its attachment to proteins contribute to this deficiency. Therapies targeted against myeloperoxidase may boost antioxidant defence and slow the onset and progression of lung disease in cystic fibrosis.


Asunto(s)
Fibrosis Quística/metabolismo , Glutatión/química , Oxígeno/química , Antioxidantes/química , Lavado Broncoalveolar , Líquido del Lavado Bronquioalveolar/química , Estudios de Casos y Controles , Niño , Preescolar , Glutatión/análogos & derivados , Glutatión/metabolismo , Humanos , Ácido Hipocloroso/química , Inflamación , Pulmón/metabolismo , Espectrometría de Masas , Neutrófilos/metabolismo , Estrés Oxidativo , Peroxidasa/química , Radiografía Torácica , Sistema Respiratorio/metabolismo , Estudios Retrospectivos , Sulfonas/metabolismo , Tomografía Computarizada por Rayos X
3.
Rheumatology (Oxford) ; 53(11): 1958-65, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24899662

RESUMEN

OBJECTIVES: The aims of this study were to establish whether, in patients with gout, MPO is released from neutrophils and urate is oxidized to allantoin and if these effects are attenuated by allopurinol. METHODS: MPO, urate, allantoin and oxypurinol were measured in plasma from 54 patients with gout and 27 healthy controls. Twenty-three patients had acute gout, 13 of whom were receiving allopurinol, and 31 had intercritical gout, 20 of whom were receiving allopurinol. Ten additional gout patients had samples collected before and after 4 weeks of allopurinol. RESULTS: Plasma MPO and its specific activity were higher (P < 0.05) in patients with acute gout not receiving allopurinol compared with controls. MPO protein in patients' plasma was related to urate concentration (r = 0.5, P < 0.001). Plasma allantoin was higher (P < 0.001) in all patient groups compared with controls. In controls and patients not receiving allopurinol, allantoin was associated with plasma urate (r = 0.62, P < 0.001) and MPO activity (r = 0.45, P < 0.002). When 10 patients were treated with allopurinol, it lowered their plasma urate and allantoin (P = 0.002). In all patients receiving allopurinol, plasma allantoin was related to oxypurinol (r = 0.65, P < 0.0001). Oxypurinol was a substrate for purified MPO that enhanced the oxidation of urate. CONCLUSION: Increased concentrations of urate in gout lead to the release of MPO from neutrophils and the oxidation of urate. Products of MPO and reactive metabolites of urate may contribute to the pathology of gout and hyperuricaemia. At low concentrations, oxypurinol should reduce inflammation, but high concentrations may contribute to oxidative stress.


Asunto(s)
Alopurinol/uso terapéutico , Gota/metabolismo , Hiperuricemia/sangre , Estrés Oxidativo , Peroxidasa/sangre , Ácido Úrico/sangre , Adulto , Anciano , Anciano de 80 o más Años , Ensayo de Inmunoadsorción Enzimática , Femenino , Gota/tratamiento farmacológico , Gota/etiología , Supresores de la Gota/uso terapéutico , Humanos , Hiperuricemia/complicaciones , Masculino , Espectrometría de Masas , Persona de Mediana Edad , Oxidación-Reducción
4.
PLoS One ; 13(3): e0192952, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29590135

RESUMEN

Myeloperoxidase (MPO)-derived oxidants have emerged as a key contributor to tissue damage in inflammatory conditions such as cardiovascular disease. Pro-myeloperoxidase (pro-MPO), an enzymatically active precursor of myeloperoxidase (MPO), is known to be secreted from cultured bone marrow and promyelocytic leukemia cells, but evidence for the presence of pro-MPO in circulation is lacking. In the present study, we used a LC-MS/MS in addition to immunoblot analyses to show that pro-MPO is present in human blood plasma. Furthermore, we found that pro-MPO was more frequently detected in plasma from patients with myocardial infarction compared to plasma from control donors. Our study suggests that in addition to mature MPO, circulating pro-MPO may cause oxidative modifications of proteins thereby contributing to cardiovascular disease.


Asunto(s)
Enfermedades Cardiovasculares/sangre , Enfermedades Cardiovasculares/enzimología , Precursores Enzimáticos/sangre , Peroxidasa/sangre , Secuencia de Aminoácidos , Animales , Células CHO , Enfermedades Cardiovasculares/metabolismo , Cricetinae , Cricetulus , Células HL-60 , Halogenación , Humanos , Immunoblotting , Infarto del Miocardio/sangre , Infarto del Miocardio/enzimología , Infarto del Miocardio/metabolismo , Oxidación-Reducción , Conejos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA